Have you received Axicabtagene ciloleucel (also known as Yescarta or Axi-cel) for relapsed or refractory diffuse large B-cell lymphoma? Do you have experience of relapsed or refractory DLBCL? If so, please get in touch to share your experience with us.
Your voice will be vital in helping us to show why this medicine should be made available on the NHS in England – so that plenty more people with DLBCL can benefit from this life-saving treatment too. You can comment below or get in touch with us at policy@bloodcancer.org.uk
Your response will be treated in the strictest confidence.